FDA Investigator Chilton L Ng

Chilton L Ng has conducted inspections on 18 sites in 2 countries as of 07 Feb 2007. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
18
Last Inspection Date:
07 Feb 2007
Investigator Role:
FDA Investigator
Redica ID:
100007281
Countries of Inspections:
United States of America, China
FDA Investigators that have inspected at least one site in common with Chilton L Ng:
Adrienne Morgan, Alan E Mehl, Alan L Truong, Amir A Abdalla, Amy E Devine, Anthony R Bucks, Aref Mel Demerdash, Ariel Cruz Figueroa, Barbara I Rogolsky, Binh T Nguyen, Brenda C Hamilton, Brett R Havranek, Brittany D Terhar, Carl A Huffman, III, Carl J Montgomery, Chris A Sack, Cody D Rickman, Cynthia C Smith, PhD, Cynthia L Evitt, Cynthia M Goudeau, Damaris Y Hernandez, Dana D Carter, SR DDS, Danial S Hutchison, Daniel R Hurt, David J Eide, Dennis Cantellops Paite, Dewayne E Whitlock, Diane L Raccasi, Dina K West, Dr. Sriram Subramaniam, PhD, Eric M Mueller, PharmD, Evelyne L Weaver, Farhana Khan, Frank J Mazzoni, Gretchen Lf Trendel, Guerda Prophete, Gwyn G Dickinson, Ingrid Y Johnson, Ivis L Negron, J Michael Cannon, PhD, James D Planchon, James P Mcreavey, Jeannie M Vonderbrink, Jill J Tillman, Joan M Nandrea, John T Vonderbrink, Jonathan R Campos, Joohi Castelvetere, Jorge L Guadalupe, Joseph R Lambert, Judith Hillegas, Julie N Vosilus, Kellia N Hicks, Kristi B Panzer, Linda R Kuchenthal, Linhart, Linwood R Daughtry, Lisa L Flores, Lisa L Gilliam, Lori A Gioia, Luis A Dasta, Marcus F Yambot, Marie F Morin, Marion D Wimberly, Jr, Mark E Parmon, Mark S Ross, Martin K Yau, PhD, Matthew B Casale, Matthew R Sleeter, Megan M Kirk, Megan T Ziegler, Michael C Zubelewicz, Michael S Smoker, Michele L Obert, Michele Perry Williams, Michele R Cromer, Minerva Rogers, Monique M Brooks, Nadeem I Chaudhry, Nadine Nanko Johnson, Neal L Adams, Norman K Starks, Paraluman S Leonin, Patrick L Wisor, Rachel C Harrington, Rachel Collen, Raymond Valdivia, Rebecca Rodriguez, Rita K Kabaso, Robert J Ham, Robin K Hatfield, Robin K Reel, Ruben C Ayala, PharmD, Sharon K Thoma, PharmD, Shirley J Berryman, Shwnji Susie Lee, Steven D Kehoe, Steven P Donald, Susanna E Ford, Susie H Lee, Suzanne N Vallez, Tamara J Umscheid, Tara L Breckenridge, Tara L Greene, Tara L King, Thomas J Arista, Torrey M Ward, Tristian E Strait, Uduak M Inokon, Veronica Fuentes, MS, Vickie J Kanion, Victoria A Wagoner, Vinh T Phan, Walden H Lee, Warren J Lopicka, Wayne D Mcgrath, Xiaohan Cai, PhD, Yiyue Zhang (nmi), PhD, Zachary A Bogorad

Chilton L Ng's Documents

Publish Date Document Type Title
August, 2003 FDA 483 Nostrum Laboratories, Inc. - Form 483, 2003-08-22
January, 2003 EIR Zoetis LLC - EIR, 2003-01-31
October, 2005 FDA 483 Huadong Medicine Co. Ltd. - Form 483, 2005-10-20
November, 2005 FDA 483 Huzhou Zhanwang Pharmaceutical Co., Ltd. - Form 483, 2005-11-03
February, 2007 EIR TriRx Shawnee LLC - EIR, 2007-02-16
February, 2004 FDA 483 Nostrum Laboratories, Inc. - Form 483, 2004-02-11
January, 2003 FDA 483 Zoetis LLC - Form 483, 2003-01-31
June, 2002 FDA 483 Nostrum Laboratories, Inc. - Form 483, 2002-06-18
November, 2004 EIR Catalent CTS, LLC - EIR, 2004-11-29
November, 2005 EIR Huzhou Zhanwang Pharmaceutical Co., Ltd. - EIR, 2005-11-03
March, 2004 FDA 483 Custom Industrial Analysis Laboratories - Form 483, 2004-03-03
September, 2005 FDA 483 MRIGlobal - Form 483, 2005-09-09
October, 2005 EIR Huadong Medicine Co. Ltd. - EIR, 2005-10-20
November, 2004 FDA 483 Catalent CTS, LLC - Form 483, 2004-11-29
November, 2004 FDA 483 Response Catalent CTS, LLC - Form 483R, 2004-12-09
November, 2005 FDA 483 Response Huzhou Zhanwang Pharmaceutical Co., Ltd. - Form 483R, 2005-12-14

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more